XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,000 | +7.1% | 5,935 | +77.6% | 0.00% | – |
| Q2 2021 | $14,000 | -67.4% | 3,342 | -65.1% | 0.00% | -100.0% |
| Q1 2021 | $43,000 | -41.1% | 9,564 | -35.6% | 0.00% | -50.0% |
| Q4 2020 | $73,000 | -69.7% | 14,846 | -63.4% | 0.00% | -33.3% |
| Q3 2020 | $241,000 | +1105.0% | 40,585 | +436.6% | 0.00% | +200.0% |
| Q2 2020 | $20,000 | +400.0% | 7,563 | +253.4% | 0.00% | – |
| Q1 2020 | $4,000 | -92.7% | 2,140 | -72.5% | 0.00% | -100.0% |
| Q4 2019 | $55,000 | +1000.0% | 7,793 | +1381.6% | 0.01% | – |
| Q3 2019 | $5,000 | -88.1% | 526 | -85.7% | 0.00% | -100.0% |
| Q2 2019 | $42,000 | +147.1% | 3,671 | +261.3% | 0.00% | +200.0% |
| Q4 2018 | $17,000 | -76.4% | 1,016 | -75.1% | 0.00% | -80.0% |
| Q3 2018 | $72,000 | – | 4,088 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |